We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current APH market cap is 231.36M. The company's latest EPS is GBP -0.0613 and P/E is -7.01.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 135.64M | 129.8M | 163.21M | 167.42M | 180.68M |
| Operating Income | 35.63M | 16.62M | 21.58M | -17.69M | -38.44M |
| Net Income | 25.01M | 8.03M | 7.32M | -21.21M | -33.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 407.64M | 508.85M | 503.49M | 509.15M | 414.92M |
| Total Liabilities | 133.46M | 227.9M | 221M | 243.64M | 197.05M |
| Total Equity | 274.18M | 280.96M | 282.49M | 265.52M | 217.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | 35.76M | 41.57M | 38.66M | 20.97M | 31.41M |
| Investing | -3.28M | -85.86M | -4.6M | -17.03M | -918k |
| Financing | -25.2M | 55.75M | -34.34M | -876k | -39.19M |
| Market Cap | 231.36M |
| Price to Earnings Ratio | -7.01 |
| Price to Sales Ratio | 1.29 |
| Price to Cash Ratio | 10.36 |
| Price to Book Ratio | 1.07 |
| Dividend Yield | - |
| Shares Outstanding | 540.57M |
| Average Volume (1 week) | 1.76M |
| Average Volume (1 Month) | 1.61M |
| 52 Week Change | -10.08% |
| 52 Week High | 49.20 |
| 52 Week Low | 24.55 |
| Spread (Intraday) | 0.2 (0.47%) |
| Company Name | Alliance Pharma Plc |
| Address |
avonbridge house wiltshire SN15 2BB |
| Website | https://www.alliancepharmaceuticals.com |
| Industry | diversified investment holding (D13) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
